About CLINUVEL

Mrs Brenda Shanahan

BEc, BCom

Non-Executive Director

Mrs Shanahan has a longstanding background in finance in Australian and overseas’ economies and share markets and is a Fellow of the Institute of Directors. She is currently Chair of St Vincent's Medical Research Institute in Melbourne, a non-executive Director of DMP Asset Management, a non-executive Director of Challenger Limited (ASX:CGF) and a Director of the Kimberley Foundation of Australia. Mrs Shanahan is the former Chair of Challenger Listed Investments Ltd, the reporting entity for Challenger Kenedix Japan Trust (ASX:CKT), Challenger Infrastructure Fund (ASX:CIF), Challenger Diversified Property Group (ASX: CDI) and Challenger Wine Trust (ASX:CWT).

She is a former member of the Australian Stock Exchange and former executive director of a stockbroking firm, a fund management company and an actuarial company. Mrs Shanahan is well known in the business and financial community; her insights add significant value to the current Board and the company. Mrs Shanahan was Non-Executive Chair of the CLINUVEL Board from late 2007 until July 2010.

Latest Company Announcements

07 November 2017

Response to ASX Price Query

Response to ASX Price Query

Read More
30 October 2017

Appendix 4C

Appendix 4C

Read More
26 October 2017

Appendix 4G

Appendix 4G

Read More
16 October 2017

CLINUVEL Newsletter - October 2017

I am addressing you during quite a turbulent period, when our teams are preparing various dossiers to meet regulatory obligations in Europe and the US

Read More
10 October 2017

CLINUVEL CONFIRMS AGM DATE

CLINUVEL PHARMACEUTICALS LTD today announced it will hold its 2017 Annual General Meeting of shareholders on Tuesday 28 November 2017

Read More

Quick Links